Sign in
Taking peopleNo phase

Cancer cells in the blood and their link to blood clots in veins

Studies how tumor cells in blood relate to vein clots in people with cancer.

Key facts

Who runs it
Chang Gung Memorial Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
Status
Recruiting
People taking part
120 people, planned
Started
28 May 2024
Expected to end
30 Apr 2027
Type of study
Observational, 2 groups
Treatments tested
  • CTCs/CTMs culture
Record updated
24 September 2025

Who can take part

The trial is looking for adults with a blood clot in a vein who had the clot removed through a thin tube (catheter). People with cancer and people without cancer can join.

Age
18 Years to 80 Years
Sex
All sexes
Disease stage
Venous thrombosis (a blood clot in a vein). People with cancer must have a malignant tumor shown by pathology. People without cancer must have had no cancer in five years.
Earlier treatment
Must have had catheter-based thrombectomy (clot removal through a thin tube) and agree to the thrombectomy.
Main reasons for not taking part
  • Shock
  • Severe sepsis (a serious body-wide infection)
  • For the group without cancer: cancer within five years
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • age≧18
  • participants (1)participants without cancer: without cancer in five years (2)participants with cancer:pathology reveal have malignant tumor
  • patients who underwent catheter-based thrombectomy
  • agree do the thrombectomy

Who cannot take part

  • participants without cancer (1).shock (2).severe sepsis (3).with cancer in five years
  • participants with cancer (1).shock (2).severe sepsis

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Venous thrombosis

This trial is currently available in Taiwan.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Research indicates a strong correlation between cancer and thrombosis, with approximately 20% of blood clots in the U.S. being cancer-related, according to CDC data. Cancer patients face a 4-7 times higher risk of thrombosis compared to non-cancer individuals. Certain cancer treatments, such as chemotherapy and targeted therapy, elevate the likelihood of venous thromboembolism (VTE). Cancer patients with VTE exhibit a significantly higher hazard ratio (H.R.) of 3.4 compared to those without VTE.

Read full original descriptionShow less

This study aims to explore three main topics: (1) Comparing the differences and similarities of leukocyte populations between cancer-associated thrombosis (CAT) and venous thromboembolism (VTE). (2) Characterizing the factors contributing to increased incidence of cancer-associated thrombosis (CAT), with the hypothesis that circulating tumor microemboli (CTM) may express more thrombosis-related proteins than CTCs. (3) Understanding the effects of aspirin or NOACs on cancer-associated thrombosis and CTM formation.

The 2 groups in the trial

  • cancer for CTC culture

    a thrombosis patient with cancer .

    Treatment: CTCs/CTMs culture

  • health for CTC culture

    a thrombosis patient without cancer

    Treatment: CTCs/CTMs culture

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
Plain-language title
Cancer cells in the blood and their link to blood clots in veinsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06672250, who can take part
Record updated
24 September 2025